Annabel J. Curle , Josephine L. Barnes , Robert Owen , Roger A. Barker , Alicia El Haj , Stuart J. Forbes , Cedric Ghevaert , Richard OC. Oreffo , Felicity RAJ. Rose , Molly M. Stevens , Zoe Hewitt
{"title":"十年进展:英国再生医学研究的成就与未来挑战","authors":"Annabel J. Curle , Josephine L. Barnes , Robert Owen , Roger A. Barker , Alicia El Haj , Stuart J. Forbes , Cedric Ghevaert , Richard OC. Oreffo , Felicity RAJ. Rose , Molly M. Stevens , Zoe Hewitt","doi":"10.1016/j.regen.2024.100078","DOIUrl":null,"url":null,"abstract":"<div><p>The final United Kingdom Regenerative Medicine Platform (UKRMP) conference held in Edinburgh's iconic McEwan Hall between 8th and November 10, 2023 saw a gathering of nearly 200 international delegates presenting exceptional science and celebrating a decade of this initiative. The UKRMP had the core mission to break down the major barriers to clinical translation of regenerative medicine products. UKRMP2 was established as three hubs that worked closely with industry and regulators: 1) Pluripotent Stem Cells and Engineered Cells, 2) Engineered Cell Environments, and 3) Smart Materials. In this meeting report, we outline the original aims of UKRMP, examine how it achieved critical mass, summarise the major developments that the UKRMP hubs delivered, and examine some unresolved challenges that still lie ahead in the field of regenerative medicine.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"24 ","pages":"Article 100078"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468498824000027/pdfft?md5=34a511e59647290cfb705cc6456747e9&pid=1-s2.0-S2468498824000027-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom\",\"authors\":\"Annabel J. Curle , Josephine L. Barnes , Robert Owen , Roger A. Barker , Alicia El Haj , Stuart J. Forbes , Cedric Ghevaert , Richard OC. Oreffo , Felicity RAJ. Rose , Molly M. Stevens , Zoe Hewitt\",\"doi\":\"10.1016/j.regen.2024.100078\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The final United Kingdom Regenerative Medicine Platform (UKRMP) conference held in Edinburgh's iconic McEwan Hall between 8th and November 10, 2023 saw a gathering of nearly 200 international delegates presenting exceptional science and celebrating a decade of this initiative. The UKRMP had the core mission to break down the major barriers to clinical translation of regenerative medicine products. UKRMP2 was established as three hubs that worked closely with industry and regulators: 1) Pluripotent Stem Cells and Engineered Cells, 2) Engineered Cell Environments, and 3) Smart Materials. In this meeting report, we outline the original aims of UKRMP, examine how it achieved critical mass, summarise the major developments that the UKRMP hubs delivered, and examine some unresolved challenges that still lie ahead in the field of regenerative medicine.</p></div>\",\"PeriodicalId\":94333,\"journal\":{\"name\":\"Journal of immunology and regenerative medicine\",\"volume\":\"24 \",\"pages\":\"Article 100078\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2468498824000027/pdfft?md5=34a511e59647290cfb705cc6456747e9&pid=1-s2.0-S2468498824000027-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of immunology and regenerative medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468498824000027\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunology and regenerative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468498824000027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom
The final United Kingdom Regenerative Medicine Platform (UKRMP) conference held in Edinburgh's iconic McEwan Hall between 8th and November 10, 2023 saw a gathering of nearly 200 international delegates presenting exceptional science and celebrating a decade of this initiative. The UKRMP had the core mission to break down the major barriers to clinical translation of regenerative medicine products. UKRMP2 was established as three hubs that worked closely with industry and regulators: 1) Pluripotent Stem Cells and Engineered Cells, 2) Engineered Cell Environments, and 3) Smart Materials. In this meeting report, we outline the original aims of UKRMP, examine how it achieved critical mass, summarise the major developments that the UKRMP hubs delivered, and examine some unresolved challenges that still lie ahead in the field of regenerative medicine.